Transcriptional mapping and genomic analysis of the cardiac atria and ventricles

Physiological Genomics

Volumn 12, Issue , 2003, Pages 53-60

  Zhao, Xiao Song ^a   Gallardo, Teresa D ^a   Lin, Ling ^a   Schageman, Jeoffrey J ^a   Shohet, Ralph V ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Atrium; Gene expression; Microarray; Myocyte enhancer factor 2

Indexed keywords

MYOCYTE ENHANCER FACTOR 2; DNA BINDING PROTEIN; MESSENGER RNA; MYOCYTE SPECIFIC ENHANCER BINDING FACTOR 2; MYOCYTE-SPECIFIC ENHANCER-BINDING FACTOR 2; MYOGENIC FACTOR; TRANSCRIPTION FACTOR;

ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; GENE EXPRESSION REGULATION; GENE MAPPING; GENETIC ANALYSIS; GENETIC CONSERVATION; GENOMICS; HEART ATRIUM; HEART DEVELOPMENT; HEART VENTRICLE; HUMAN; HUMAN TISSUE; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FAMILY; RELIABILITY; TRANSCRIPTION REGULATION; VENOUS RETURN; ANIMAL; BINDING SITE; BIOSYNTHESIS; C57BL MOUSE; COMPARATIVE STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; HEART; HISTOLOGY; IN SITU HYBRIDIZATION; MALE; METABOLISM; MOUSE; TRANSGENIC MOUSE;

ANIMALIA; MURINAE;

ANIMALS; BINDING SITES; CONSERVED SEQUENCE; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENOMICS; HEART; HEART ATRIA; HEART VENTRICLES; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOGENIC REGULATORY FACTORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0037180748     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00086.2002     Document Type: Article

References (33)

1. Black BL, Martin JF, and Olson EN. The mouse MRF4 promoter is trans-activated directly and indirectly by muscle-specific transcription factors. J Biol Chem 270: 2889-2892, 1995.
2. Boknik P, Unkel C, Kirchhefer U, Kleideiter U, Klein-Wiele O, Knapp J, Linck B, Luss H, Muller FU, Schmitz W, Vahlensieck U, Zimmermann N, Jones LR, and Neumann J. Regional expression of phospholamban in the human heart. Cardiovasc Res 43: 67-76, 1999.
3. Chen JN and Fishman MC. Genetics of heart development. Trends Genet 16: 383-388, 2000.
4. Dixon JE and McKinnon D. Quantitative analysis of potassium channel mRNA expression in atrial and ventricular muscle of rats. Circ Res 75: 252-260, 1994.
5. East JM. Sarco(endo)plasmic reticulum calcium pumps: recent advances in our understanding of structure/function and biology (review). Mol Membr Biol 17: 189-200, 2000.
6. Eisen MB and Brown PO. DNA arrays for analysis of gene expression. Methods Enzymol 303: 179-205, 1999.
7. + channel beta subunit expressed in human heart. Proc Natl Acad Sci USA 92: 6309-6313, 1995.
8. Epstein CB, Hale W IV, and Butow RA. Numerical methods for handling uncertainty in microarray data: an example analyzing perturbed mitochondrial function in yeast. Methods Cell Biol 65: 439-452, 2001.
9. Fernandez E, Siddiquee Z, and Shohet RV. Apoptosis and proliferation in the neonatal murine heart. Dev Dyn 221: 302-310, 2001.
10. Forbes MS, Van Niel EE, and Purdy-Ramos SI. The atrial myocardial cells of mouse heart: a structural and stereological study. J Struct Biol 103: 266-279, 1990.
11. Franco D, Lamers WH, and Moorman AF. Patterns of expression in the developing myocardium: towards a morphologically integrated transcriptional model. Cardiovasc Res 38: 25-53, 1998.
12. Han J and Molkentin JD. Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology. Trends Cardiovasc Med 10: 19-22, 2000.
13. Hardison RC. Conserved noncoding sequences are reliable guides to regulatory elements. Trends Genet 16: 369-372, 2000.
14. Hardison RC, Oeltjen J, and Miller W. Long human-mouse sequence alignments reveal novel regulatory elements: a reason to sequence the mouse genome. Genome Res 7: 959-966, 1997.
15. Kato M, Egashira K, and Takeshita A. Cardiac angiotensin II receptors are downregulated by chronic angiotensin II infusion in rats. Jpn J Pharmacol 84: 75-77, 2000.
16. Kelly RG, Zammit PS, and Buckingham ME. Cardiosensor mice and transcriptional subdomains of the vertebrate heart. Trends Cardiovasc Med 9: 3-10, 1999.
17. Klein I. Thyroxine-induced cardiac hypertrophy: time course of development and inhibition by propranolol. Endocrinology 123: 203-210, 1988.
18. Kolodziejczyk SM, Wang L, Balazsi K, DeRepentigny Y, Kothary R, and Megeney LA. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium. Curr Biol 9: 1203-1206, 1999.
19. Koss KL, Ponniah S, Jones WK, Grupp IL, and Kranias EG. Differential phospholamban gene expression in murine cardiac compartments. Molecular and physiological analyses. Circ Res 77: 342-353, 1995.
20. Lennon G, Auffray C, Polymeropoulos M, and Soares MB. The IMAGE Consortium: an integrated molecular analysis of genomes and their expression. Genomics 33: 151-152, 1996.
21. Lin Q, Schwarz J, Bucana C, and Olson EN. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276: 1404-1407, 1997.
22. Loots GG, Ovcharenko I, Pachter L, Dubchak I, and Rubin EM. For comparative sequence-based discovery of functional transcription factor binding sites. Genome Res 12: 832-839, 2002.
23. McKinsey TA, Zhang CL, and Olson EN. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc Natl Acad Sci USA 97: 14400-14405, 2000.
24. Minajeva A, Kaasik A, Paju K, Seppet E, Lompre AM, Veksler V, and Ventura-Clapier R. Sarcoplasmic reticulum function in determining atrioventricular contractile differences in rat heart. Am J Physiol Heart Circ Physiol 273: H2498-H2507, 1997.
25. Naya FJ, Wu C, Richardson JA, Overbeek P, and Olson EN. Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development 126: 2045-2052, 1999.
26. Olgin J and Rubart M. Remodeling of the atria and ventricles due to rate. In: Cardiac Electrophysiology: From Cell to Bedside (3rd ed.), edited by Zipes D and Jalife J. Philadelphia, PA: Saunders, 1999, chapt. 42 p. 364-378.
27. Pawloski-Dahm CM, Song G, Kirkpatrick DL, Palermo J, Gulick J, Dorn GW II, Robbins J, and Walsh RA. Effects of total replacement of atrial myosin light chain-2 with the ventricular isoform in atrial myocytes of transgenic mice. Circulation 97: 1508-1513, 1998.
28. Schageman JJ, Basit M, Gallardo TD, Garner HR, and Shohet RV. MarC-V: a spreadsheet-based tool for analysis, normalization, and visualization of single cDNA microarray experiments. Biotechniques 32: 338-340, 342, 344, 2002.
29. Shelton JM, Lee MH, Richardson JA, and Patel SB. Microsomal triglyceride transfer protein expression during mouse development. J Lipid Res 41: 532-537, 2000.
30. Soonpaa MH and Field LJ. Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice. Am J Physiol Heart Circ Physiol 266: H1439-H1445, 1994.
31. Touyz RM, Sventek P, Lariviere R, Thibault G, Fareh J, Reudelhuber T, and Schiffrin EL. Cytosolic calcium changes induced by angiotensin II in neonatal rat atrial and ventricular cardiomyocytes are mediated via angiotensin II subtype 1 receptors. Hypertension 27: 1090-1096, 1996.
32. Wang Z, Yue L, White M, Pelletier G, and Nattel S. Differential distribution of inward rectifier potassium channel transcripts in human atrium versus ventricle. Circulation 98: 2422-2428, 1998.
33. Wasserman WW, Palumbo M, Thompson W, Fickett JW, and Lawrence CE. Human-mouse genome comparisons to locate regulatory sites. Nat Genet 26: 225-228, 2000.